Literature DB >> 21059493

Proinflammatory cytokine gene polymorphisms in Behçet's disease.

Aliakbar Amirzargar1, Farhad Shahram, Enayat Nikoopour, Nima Rezaei, Keyvan Saeedfar, Naghmeh Ziaei, Fereydoun Davatchi.   

Abstract

Behçet's disease (BD) is a chronic, systemic disease, characterized by oral and genital lesions, and ocular inflammation. There is evidence indicating altered levels of proinflammatory cytokines, such as interleukin (IL)-6 and tumor necrosis factor alpha (TNF-α) in patients with BD. This study involved 150 patients with BD and 140 healthy controls, and investigated the role of proinflammatory cytokine gene polymorphisms in the disease. The frequency of the TNF-α (-238) G/G genotype was significantly higher in the patient group, compared to the controls (p < 0.001), whilst the G/A genotype was significantly lower in the patients with BD (p < 0.001). Patients with BD showed a significant increase in the TNF-α (- 308, - 238) GG haplotype (p < 0.001), whilst there was a significant decrease in the GA haplotype (p < 0.001). The heterozygous, IL-6 (- 174) C/G genotype (p = 0.005), and the IL-6 (- 174, nt565) haplotype CG (p < 0.001), were significantly decreased in the patient group. The increased production of proinflammatory cytokines in BD could be a consequence of specific, cytokine gene polymorphisms. Particular genotypes and haplotypes in TNF-α were over-represented in BD, which may, in turn, predispose individuals to this disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21059493     DOI: 10.1684/ecn.2009.0209

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  17 in total

Review 1.  Association of cytokine gene polymorphisms (IL‑6, IL‑12B, IL‑18) with Behcet's disease : A meta-analysis.

Authors:  Y Xu; K Zhou; Z Yang; F Li; Z Wang; F Xu; C He
Journal:  Z Rheumatol       Date:  2016-11       Impact factor: 1.372

2.  Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus.

Authors:  Arezou Rezaei; Vahid Ziaee; Fatemeh Tahghighi Sharabian; Sara Harsini; Maryam Mahmoudi; Samaneh Soltani; Maryam Sadr; Mohammad Hassan Moradinejad; Yahya Aghighi; Nima Rezaei
Journal:  Clin Rheumatol       Date:  2015-01-30       Impact factor: 2.980

Review 3.  Interleukin 6 and cognitive dysfunction.

Authors:  Isabel Trapero; Omar Cauli
Journal:  Metab Brain Dis       Date:  2014-04-30       Impact factor: 3.584

Review 4.  Associations between interleukin-1 polymorphisms and susceptibility to vasculitis: a meta-analysis.

Authors:  G G Song; J-H Kim; Y H Lee
Journal:  Z Rheumatol       Date:  2016-05       Impact factor: 1.372

5.  Association between rs1800795 polymorphisms in the interleukin-6 gene and vasculitis: A meta-analysis.

Authors:  Jae Hyun Jung; Hongdeok Seok; Sung Jae Choi; Gwan Gyu Song; Youngjin Han
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

6.  Significance of IL-1RA Polymorphism in Iranian Patients with Inflammatory Bowel Disease.

Authors:  Nasser Ebrahimi Daryani; Maryam Sadr; Shirin Moossavi; Sepideh Shahkarami; Samaneh Soltani; Elham Farhadi; Nima Rezaei
Journal:  Dig Dis Sci       Date:  2014-12-03       Impact factor: 3.199

7.  The Immunogenetics of Behcet's Disease.

Authors:  Mustafa Anıl Yılmaz; Ümit Türsen
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

8.  Malassezia Yeast and Cytokine Gene Polymorphism in Atopic Dermatitis.

Authors:  Charu Jain; Shukla Das; V G Ramachandran; Rumpa Saha; S N Bhattacharya; Sajad Dar
Journal:  J Clin Diagn Res       Date:  2017-03-01

9.  Inflammation-related cytokine gene polymorphisms in Behçet's disease.

Authors:  Fahda Al-Okaily; Misbahul Arfin; Seham Al-Rashidi; Maysoon Al-Balawi; Abdulrahman Al-Asmari
Journal:  J Inflamm Res       Date:  2015-09-28

10.  Polymorphisms in the tumor necrosis factor gene and susceptibility to Behcet's disease: an updated meta-analysis.

Authors:  Min Zhang; Wang-Dong Xu; Peng-Fei Wen; Yan Liang; Jie Liu; Hai-Feng Pan; Dong-Qing Ye
Journal:  Mol Vis       Date:  2013-09-12       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.